Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$184,712
+$43,988 QoQ
Shares Held
154
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#4,438
of 4,605 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261620 INVESTMENT ADVISORS, INC. holds $6,968,762 across 10 Drug Manufacturers - General names. LLY ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,146 | $1,798,219 | |
| 2 | NVS |
Novartis AG
|
9,183 | $1,439,159 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
17,612 | $1,014,803 | |
| 4 | PFE |
Pfizer Inc
|
36,100 | $869,288 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,976 | $755,007 | |
| 6 | JNJ |
Johnson & Johnson
|
2,820 | $716,195 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
154 | $184,712 | |
| 8 | MRK |
Merck & Co., Inc.
|
842 | $108,197 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $184,712 | 154 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $140,724 | 153 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $169,799 | 158 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $138,103 | 181 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $152,787 | 196 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $189,133 | 229 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $186,052 | 241 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $219,713 | 248 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $214,575 | 237 | Shares | Sole | 2024-07-23 | |
| 2023-09-30 | $211,092 | 393 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||